2.4 Eligibility criteria
Patients in this study should meet the following criteria: Pathological
diagnosis of NSCLC stage III/IV; One or more two-dimensional measurable
lesions; 18 <
age
< 80; Karnofsky performance status (KPS) score ≥ 60 or
Zubrod-ECOG-WHO (ZPS) score ≤ 2; Average life expectancy ≥3 months;
normal heart, bone marrow, lung, liver and kidney function.